Doç. Dr. BESTE TURANLI

Yayın Ağı

Makaleler 40

1. Gaining Biological Insights Into Deltamethrin-Induced Toxicity and Resistance at the Molecular Level

Yavuz M., Kaya R. A., BEREKETOĞLU C., TURANLI B.

Journal of Biochemical and Molecular Toxicology , cilt.39, sa.9, 2025 (SCI-Expanded)

2. The Construction of ceRNA Regulatory Network Unraveled Prognostic Biomarkers and Repositioned Drug Candidates for the Management of Pancreatic Ductal Adenocarcinoma

Aydin B., Okutan K., Aydogan O. O., Sinha R., TURANLI B.

Current Issues in Molecular Biology , cilt.47, sa.7, 2025 (SCI-Expanded)

3. Public health challenges after the February 6 earthquakes: A comprehensive review of immediate and long-term impacts in Türkiye

Koçer A. T., Akpek A., Vural A., Aslan A., Erkoç A., Özen A. M., et al.

International Journal of Disaster Risk Reduction , cilt.114, 2024 (SCI-Expanded)

4. Integrated systems biology analysis of acute lymphoblastic leukemia: unveiling molecular signatures and drug repurposing opportunities

Budak B., Tükel E. Y., TURANLI B., Kiraz Y.

Annals of Hematology , cilt.103, sa.10, ss.4121-4134, 2024 (SCI-Expanded)

5. Comparative analysis of diisononyl phthalate and di(isononyl)cyclohexane-1,2 dicarboxylate plasticizers in regulation of lipid metabolism in 3T3-L1 cells

BEREKETOĞLU C., Häggblom I., TURANLI B., Pradhan A.

Environmental Toxicology , cilt.39, sa.3, ss.1245-1257, 2024 (SCI-Expanded)

6. DCDA: CircRNA–Disease Association Prediction with Feed-Forward Neural Network and Deep Autoencoder

Turgut H., TURANLI B., BOZ B.

Interdisciplinary Sciences – Computational Life Sciences , cilt.16, sa.1, ss.91-103, 2024 (SCI-Expanded) Sürdürülebilir Kalkınma

7. Genome-scale metabolic models in translational medicine: the current status and potential of machine learning in improving the effectiveness of the models

TURANLI B., Gulfidan G., Aydogan O. O., KULA C., Selvaraj G., ARGA K. Y.

Molecular Omics , cilt.20, sa.4, ss.234-247, 2024 (SCI-Expanded) Sürdürülebilir Kalkınma

8. Decoding Systems Biology of Inflammation Signatures in Cancer Pathogenesis: Pan-Cancer Insights from 12 Common Cancers

TURANLI B.

Omics : a journal of integrative biology , cilt.27, sa.10, ss.483-493, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

9. Idiopathic Pulmonary Fibrosis Molecular Substrates Revealed by Competing Endogenous RNA Regulatory Networks

Kircali M. F., TURANLI B.

OMICS A Journal of Integrative Biology , cilt.27, sa.8, ss.381-392, 2023 (SCI-Expanded)

10. Epigenomic and transcriptomic landscaping unraveled candidate repositioned therapeutics for non-functioning pituitary neuroendocrine tumors.

Aydin B., Beklen H., Arga K. Y., Bayrakli F., Turanli B.

Journal of endocrinological investigation , cilt.46, ss.727-747, 2023 (SCI-Expanded)

11. Drug repositioning via host-pathogen protein-protein interactions for the treatment of cervical cancer.

Kori M., Turanli B., Arga K. Y.

Frontiers in oncology , cilt.13, ss.1096081, 2023 (SCI-Expanded)

12. Prospects of integrated multi-omics-driven biomarkers for efficient hair loss therapy from systems biology perspective

Yilmaz D. N., Aydogan O. O., Kori M., Aydin B., Rahman M. R., Moni M. A., et al.

GENE REPORTS , cilt.28, 2022 (ESCI)

13. Acute Myeloid Leukemia: New Multiomics Molecular Signatures and Implications for Systems Medicine Diagnostics and Therapeutics Innovation

Kelesoglu N., Kori M., TURANLI B., ARĞA K. Y., Yilmaz B., Duru O. A.

OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY , cilt.26, sa.7, ss.392-403, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

14. Repositioning of Anti-Inflammatory Drugs for the Treatment of Cervical Cancer Sub-Types

Kori M., ARĞA K. Y., Mardinoglu A., TURANLI B.

FRONTIERS IN PHARMACOLOGY , cilt.13, 2022 (SCI-Expanded)

15. Past, Present, and Future of Therapies for Pituitary Neuroendocrine Tumors: Need for Omics and Drug Repositioning Guidance

Aydin B., Yildirim E., ERDOĞAN O., ARĞA K. Y., Yilmaz B., BOZKURT S., et al.

OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY , cilt.26, sa.3, ss.115-129, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

16. Systems biomarkers for papillary thyroid cancer prognosis and treatment through multi-omics networks

Gulfidan G., Soylu M., Demirel D., Erdonmez H. B. C., Beklen H., ÖZBEK SARICA P., et al.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS , cilt.715, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

17. Differential Interactome Based Drug Repositioning Unraveled Abacavir, Exemestane, Nortriptyline Hydrochloride, and Tolcapone as Potential Therapeutics for Colorectal Cancers

beklen h., arslan s., Gulfidan G., Turanlı B., ÖZBEK SARICA P., Karademir Yılmaz B., et al.

Frontiers in Bioinformatics , cilt.1, 2021 (Hakemli Dergi) Sürdürülebilir Kalkınma

18. Differential Protein Interactome in Esophageal Squamous Cell Carcinoma Offers Novel Systems Biomarker Candidates with High Diagnostic and Prognostic Performance

Gulfidan G., Beklen H., Sinha I., Kucukalp F., Caloglu B., Esen I., et al.

OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY , cilt.25, ss.495-512, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

19. Systems-level biomarkers identification and drug repositioning in colorectal cancer

Beklen H., Yildirim E., Kori M., TURANLI B., ARĞA K. Y.

WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY , cilt.13, sa.7, ss.638-661, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

20. The Repertoire of Glycan Alterations and Glycoproteins in Human Cancers.

Kori M., Aydin B., Gulfidan G., Beklen H., Kelesoglu N., Caliskan Iscan A., et al.

Omics : a journal of integrative biology , cilt.25, sa.3, ss.139-168, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

21. Current State of "Omics" Biomarkers in Pancreatic Cancer

TURANLI B., Yildirim E., Gulfidan G., ARĞA K. Y., Sinha R.

JOURNAL OF PERSONALIZED MEDICINE , cilt.11, sa.2, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

22. Systems biology based drug repositioning for development of cancer therapy.

Turanli B., Altay O., Borén J., Turkez H., Nielsen J., Uhlen M., et al.

Seminars in cancer biology , cilt.68, ss.47-58, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

23. Comprehensive Analysis of RNA-Seq Gene Expression Profiling of Brain Transcriptomes Reveals Novel Genes, Regulators, and Pathways in Autism Spectrum Disorder

Rahman M. R., Petralia M. C., Ciurleo R., Bramanti A., Fagone P., Shahjaman M., et al.

BRAIN SCIENCES , cilt.10, sa.10, 2020 (SCI-Expanded)

24. Drug Repositioning for P-Glycoprotein Mediated Co-Expression Networks in Colorectal Cancer

Beklen H., Gulfidan G., ARĞA K. Y., Mardinoglu A., Turanli B.

FRONTIERS IN ONCOLOGY , cilt.10, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

25. Pan-cancer mapping of differential protein-protein interactions

Gulfidan G., Turanli B., Beklen H., Sinha R., Arga K. Y.

SCIENTIFIC REPORTS , cilt.10, sa.1, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

26. Classification of clear cell renal cell carcinoma based on PKM alternative splicing

Li X., TURANLI B., Juszczak K., Kim W., Arif M., Sato Y., et al.

HELIYON , cilt.6, sa.2, 2020 (SCI-Expanded)

27. Multi-Omic Data Interpretation to Repurpose Subtype Specific Drug Candidates for Breast Cancer

Turanli B., Karagoz K., Bidkhori G., Sinha R., Gatza M., Uhlen M., et al.

FRONTIERS IN GENETICS , cilt.10, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

28. Discovery of therapeutic agents for prostate cancer using genome-scale metabolic modeling and drug repositioning

Turanli B., Zhang C., Kim W., Benfeitas R., Uhlen M., Arga K. Y., et al.

EBIOMEDICINE , cilt.42, ss.386-396, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

29. Network-based approach to identify molecular signatures and therapeutic agents in Alzheimer's disease

Rahman M. R., Islam T., TURANLI B., Zaman T., Faruquee H. M., Rahman M. M., et al.

COMPUTATIONAL BIOLOGY AND CHEMISTRY , cilt.78, ss.431-439, 2019 (SCI-Expanded)

30. Identification of Prognostic Biomarker Signatures and Candidate Drugs in Colorectal Cancer: Insights from Systems Biology Analysis

Rahman M. R., Islam T., Gov E., Turanli B., Gulfidan G., Shahjaman M., et al.

MEDICINA-LITHUANIA , cilt.55, sa.1, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

31. Drug Targeting and Biomarkers in Head and Neck Cancers: Insights from Systems Biology Analyses

İSLAM T., RAHMAN R., GÖV E., TURANLI B., GÜLFİDAN G., HAQUE M. A., et al.

OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY , cilt.22, sa.6, ss.422-436, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

32. Drug Repositioning for Effective Prostate Cancer Treatment

TURANLI B., Grotli M., BOREN J., NIELSEN J., UHLEN M., ARĞA K. Y., et al.

FRONTIERS IN PHYSIOLOGY , cilt.9, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

33. Systems biomarkers in psoriasis: Integrative evaluation of computational and experimental data at transcript and protein levels

Sevimoglu T., Turanli B., Bereketoglu C., ARĞA K. Y., KARADAĞ A. S.

GENE , cilt.647, ss.157-163, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

34. A Network-Based Cancer Drug Discovery: From Integrated Multi-Omics Approaches to Precision Medicine

TURANLI B., Karagoz K., Gulfidan G., Sinha R., Mardinoglu A., ARĞA K. Y.

CURRENT PHARMACEUTICAL DESIGN , cilt.24, sa.32, ss.3778-3790, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

35. Transcriptomic-Guided Drug Repositioning Supported by a New Bioinformatics Search Tool: geneXpharma

Turanli B., Gulfidan G., ARĞA K. Y.

OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY , cilt.21, sa.10, ss.584-591, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma

36. Impact of SRT on the efficiency and microbial community of sequential anaerobic and aerobic membrane bioreactors for the treatment of textile industry wastewater

Yurtsever A., Calimlioglu B., ŞAHİNKAYA E.

CHEMICAL ENGINEERING JOURNAL , cilt.314, ss.378-387, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma

37. Simultaneous nitrate and perchlorate removal from groundwater by heterotrophic-autotrophic sequential system

Ucar D., Çokgör E., ŞAHİNKAYA E., Cetin U., Bereketoglu C., Calimlioglu B., et al.

INTERNATIONAL BIODETERIORATION & BIODEGRADATION , cilt.116, ss.83-90, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma

38. Effect of NaCl concentration on the performance of sequential anaerobic and aerobic membrane bioreactors treating textile wastewater

YURTSEVER A., Calimlioglu B., GÖRÜR M., ÇINAR Ö., Sahinkaya E.

CHEMICAL ENGINEERING JOURNAL , cilt.287, ss.456-465, 2016 (SCI-Expanded)

39. Tissue-Specific Molecular Biomarker Signatures of Type 2 Diabetes: An Integrative Analysis of Transcriptomics and Protein-Protein Interaction Data

Calimlioglu B., Karagoz K., Sevimoglu T., Kilic E., Gov E., ARĞA K. Y.

OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY , cilt.19, sa.9, ss.563-573, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

40. Simultaneous bioreduction of nitrate and chromate using sulfur-based mixotrophic denitrification process

ŞAHİNKAYA E., Kilic A., Calimlioglu B., TOKER Y.

JOURNAL OF HAZARDOUS MATERIALS , cilt.262, ss.234-239, 2013 (SCI-Expanded)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 24

1. Dİ(İZONONİL) SİKLOHEKSAN-1,2-DİKARBOKSİLAT MARUZİYETİ, ZEBRA BALIKLARINDA BÜYÜME İLE İLİŞKİLİ GEN İFADELERİNİ DEĞİŞTİRİR

Göyük Y., TURANLI B., BEREKETOĞLU C.

8. INTERNATIONAL FOOD, AGRICULTURE AND VETERINARY SCIENCES CONGRESS, Konya, Türkiye, 29 Mayıs 2025, (Tam Metin Bildiri)

2. Systems Biology Perspective of Gender Biases in Papillary Thyroid Cancer Diagnosis, Prognosis and Therapy

TURANLI B.

V. International Agricultural, Biological & Life Science Conference, Edirne, Türkiye, 18 - 20 Eylül 2023, (Özet Bildiri)

3. Network Based Integration of Multi-Omic Profiles to Purpose New Biomarker Candidates in Pancreatic Cancer

Yildirim Sirkeci E., TURANLI B.

5th International Eurasian Conference on Biological ad Chemical Sciences (EurasianBioChem)), Ankara, Türkiye, 23 - 25 Kasım 2022, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

4. Comparative Study on Understanding Molecular Signatures of ALL and Philedelphia Positive ALL in Adults

BUDAK B., KİRAZ Y., TURANLI B.

4th EURASIA BIOCHEMICAL APPROACHES & TECHNOLOGIES (EBAT) CONGRESS, Antalya, Türkiye, 3 - 06 Kasım 2022, (Özet Bildiri)

5. Transcriptomics-Based Drug Repurposing Unravels Novel Therapeutic Strategies in AML

KELEŞOĞLU N., Korkmaz N. S., TURANLI B., ARĞA K. Y., YILMAZ B., ATEŞ DURU Ö.

4th EURASIA BIOCHEMICAL APPROACHES & TECHNOLOGIES (EBAT) CONGRESS, Antalya, Türkiye, 3 - 06 Kasım 2022, (Özet Bildiri)

6. Multi-Omics Data Integration to Unveil Molecular Signatures and Repositioned Therapeutics in Pituitary Neuroendocrine Tumors

AYDIN B., TURANLI B.

BIOINFO 2022 Annual Conference, Daejeon, Güney Kore, 19 - 21 Ekim 2022, (Özet Bildiri)

7. Systems Biology Perspective for Elucidation of Secreted Protein Biomarkers in Alzheimer’s Disease

TURANLI B.

2nd International Natural Science, Engineering and Material Technologies Conference, Kırklareli, Türkiye, 15 - 17 Eylül 2022, (Özet Bildiri)

8. Differential Interactome Based Drug Repositioning Unraveled Potential Therapeutics for Colorectal Cancers

BEKLEN H., Arslan S., GULFİDAN G., TURANLI B., ÖZBEK SARICA P., YILMAZ B., et al.

3rd EURASIA BIOCHEMICAL APPROACHES & TECHNOLOGIES (EBAT) CONGRESS, Antalya, Türkiye, 4 - 07 Kasım 2021, (Özet Bildiri)

9. Novel Systems Biomarker Candidates with High Diagnostic and Prognostic Performance in Esophageal Squamous Cell Carcinoma

GULFİDAN G., BEKLEN H., TURANLI B., AYYILDIZ D., Sinha R., ARĞA K. Y.

3rd EURASIA BIOCHEMICAL APPROACHES & TECHNOLOGIES (EBAT) CONGRESS, Antalya, Türkiye, 4 - 07 Kasım 2021, (Özet Bildiri)

10. Identification of Cervical Cancer Sub-Type Specific Molecular Targets, Biomarkers and Repurposed Drug Candidates

TURANLI B.

3rd EURASIA BIOCHEMICAL APPROACHES & TECHNOLOGIES (EBAT) CONGRESS, Antalya, Türkiye, 4 - 07 Kasım 2021, (Özet Bildiri)

11. Decoding molecular signatures of pituitary neuroendocrine tumors’ subtypes through systems biomedicine perspective

AYDIN B., Yildirim Sirkeci E., ERDOĞAN O., BAYRAKLI F., BOZKURT S., ARĞA K. Y., et al.

5th International Symposium on Bioinformatics (InSyB2021), İstanbul, Türkiye, 15 - 17 Aralık 2021, (Özet Bildiri)

12. Drug Respositioning in Colorectal Cancer by using Co-expression Networks of P-glycoprotein

BEKLEN H., GÜLFİDAN G., ARĞA K. Y., NIELSEN J., TURANLI B.

13th The International Symposium on Health Informatics and Bioinformatics, Türkiye, 22 - 23 Ekim 2020, (Özet Bildiri) Sürdürülebilir Kalkınma

13. DRUG REPOSITIONING IN PROSTATE CANCER THROUGH GENOME-SCALE METABOLIC MODELING

AYDOĞMUŞ E. M., gülfidan g., TURANLI B., ERZİK C., DEMİR Ü., KISAAYAK ÇOLLAK F., et al.

applied bioinformatics in life sciences, Leuven, Belçika, 13 - 14 Şubat 2020 Sürdürülebilir Kalkınma

14. Identification of Systems Biomarkers and Candidate Drugs in Prostate Adenocarcinoma

GULFİDAN G., BEKLEN H., TURANLI B., ARĞA K. Y.

The 12th International Symposium on Health Informatics and Bioinformatics (HIBIT 2019), İzmir, Türkiye, 17 - 19 Ekim 2019, (Özet Bildiri)

15. Drug Repositioning And Docking Studies on Melanoma

İmat N. B., TURANLI B., ACUNER ZORLUUYSAL S. E.

The 12th International Symposium on Health Informatics and Bioinformatics (HIBIT 2019), İzmir, Türkiye, 17 - 19 Ekim 2019, (Özet Bildiri)

16. Determination Of Candidate Biomarkers Through Differential Interactome in Colorectal Adenocarcinoma

BEKLEN H., GULFİDAN G., TURANLI B., ÖZBEK SARICA P., YILMAZ B., ARĞA K. Y.

The 12th International Symposium on Health Informatics and Bioinformatics (HIBIT 2019), İzmir, Türkiye, 17 - 19 Ekim 2019, (Özet Bildiri)

17. Drug repositioning for cancer therapy by the employment of systems biology

TURANLI B., GULFİDAN G., Mardinoğlu A., ARĞA K. Y.

Cell Death: Degeneration and Regeneration Symposium, İstanbul, Türkiye, 3 - 05 Ekim 2019, (Özet Bildiri)

18. Sistem biyotıp araştırmaları için bütünleştirilmiş biyolojik ağlar yaklaşımı

ÇALIMLIOĞLU B., ARĞA K. Y.

4. ULUSAL MOLEKÜLER BİYOLOJİ VE BİYOTEKNOLOJİ KONGRESİ, Türkiye, 21 - 24 Ağustos 2015, (Özet Bildiri)

19. Multi Omic Stratejiler Yardımıyla Endometriyozis Hastalığı için Biyobelirteç Tayini

Kori M., ÇALIMLIOĞLU B., ARĞA K. Y.

4. Ulusal Moleküler Biyoloji ve Biyoteknoloji, Türkiye, 21 - 24 Ağustos 2015, (Özet Bildiri)

20. Genomic and Proteomic Candidate Biomarker Investigation for Personalized Medicine

Baran B., AKBAS M., ÇALIMLIOĞLU B., ARĞA K. Y.

3rd International Gen-Arel Molecular Biology and Genetics Student Congress, 24 - 25 Nisan 2015

21. Metabolic Variability Analysis Through Human Metabolic Model

ISLER E., Yavuz U., ÇALIMLIOĞLU B., ARĞA K. Y.

3rd International Gen-Arel Molecular Biology and Genetics Student Congress, 24 - 25 Nisan 2015

22. A novel levansucrase purified from halophilic bacteria halomonas smyrnensis AAD6T

TURANLI B., ARĞA K. Y., TOKSOY ÖNER E.

10th Carbohydrate Bioengineering Meeting (CBM10), Prague, Çek Cumhuriyeti, 21 - 24 Nisan 2013, (Özet Bildiri)

23. Determining Anti-apoptotic Efficacy of Bcl-xL Protein Encoded by a Dual Promoter Mammalian Expression Vector Developed For Biotechnological Applications

TURANLI B., GÜLÇE İZ S., GÜRHAN S. İ.

6th International Molecular Biology and Genetic Student Congress, İstanbul, Türkiye, 27 - 30 Ağustos 2012, (Özet Bildiri)

24. Use Of Microbial Fuel Cells For Electricity Generation From Wastewaters

TURANLI B., AĞIR İ., TOKER Y., ŞAHİNKAYA E., ÖZKAYA B.

2nd International 100% Renewable Energy Conference and Exhibition (IRENEC2012), İstanbul, Türkiye, 28 - 30 Haziran 2012, (Özet Bildiri)

Kitaplar 2

1. Systems Biomedicine: From genome scale molecular networks to efficacious biomarkers and therapeutic targets

TURANLI B., GÜLFİDAN G., ARĞA K. Y.

Researches on Science and Art in 21st Century Turkey, Hasan Arapgirlioğlu Atilla Atık Robert L. Elliot Edward Turgeon, Editör, Gece Kitaplığı, Ankara, ss.2380-2388, 2017

2. Proteins from Halophilic Bacteria: Purification and Their Applications

Turanlı B., Arğa K. Y.

Protein Purification - Principles and Trends, -, Editör, iConcept Press, Victoria-City, ss.1-23, 2016

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

550

H-İndeks (WoS)

Atıf (Scopus)

996

H-İndeks (Scopus)

Atıf (Scholar)

512

H-İndeks (Scholar)

Proje

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)

Proje

Açık Erişim